Europe — EMA

Oxaliplatin Thama

Oxaliplatin, the active ingredient in Oxalatin Thama, is a platinum-based chemotherapy agent presented as a sterile solution for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxalatin Thama, is a platinum-based chemotherapy agent presented as a sterile solution for intravenous infusion use. It treats colorectal cancer and other solid tumours in adult patients. GNH USA supplies Oxalatin Thama as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxalatin Thama as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxalatin Thama is a platinum‑based chemotherapeutic that acts on rapidly proliferating cancer cells within the colorectal cancer treatment pathway.

- Colorectal cancer: Improves the response to combination chemotherapy regimens such as FOLFOX. - Gastric cancer: Used in combination regimens to enhance tumour shrinkage and control of disease progression. - Pancreatic pancre disease … etc… - …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →